A new study led by the Medical Research Council's (MRC) Laboratory of Molecular Biology (LMB) has identified a new protein as ...

Roche has shared positive results from a late-stage study of its investigational therapy, inavolisib, as part of a combination treatment for advanced breast cancer.

The Department of Health and Social Care has published new terms for the UK’s Statutory Scheme for branded medicines.

Sanofi and artificial intelligence (AI) specialist Aqemia have entered into a multi-year research collaboration worth $140m ...

Novartis’ Fabhalta (iptacopan) has been approved by the US Food and Drug Administration (FDA) as the first oral monotherapy ...

Merck KGaA has announced a license agreement with Abbisko Therapeutics for pimicotinib (ABSK021), which is currently being ...

Almirall has announced a new partnership with the Barcelona Supercomputing Center-Centro Nacional de Supercomputión (BSC-CNS) ...

The European Commission (EC) has approved UCB’s Zilbrysq (zilucoplan) as an add-on therapy for certain patients with ...

AstraZeneca (AZ) and Absci have entered into a collaboration agreement worth up to $247m to develop an artificial ...

Roche has announced that it will be acquiring Carmot Therapeutics in a deal worth up to $3.1bn, giving the Swiss drugmaker ...

Eli Lilly’s non-covalent Bruton's tyrosine kinase (BTK) inhibitor Jaypirca (pirtobrutinib) has been granted accelerated ...

LifeArc has said it will commit £5m in grant funding to discover new treatments for motor neurone disease (MND) as part of a drug repurposing programme to combat high failure rates in clinical trials.